CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions
Open Access
- 13 February 2026
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 46 (1)
Abstract
Glutamate-induced oxidative cytotoxicity is a major driver of neuronal loss in neurodegenerative diseases, yet the upstream transcriptional regulators linking oxidative stress to neuronal death remain unclear despite the known involvement of the p53–GADD45α pathway. CREB2 (ATF4) is a stress-responsive transcription factor, but its role in microglia-mediated oxidative neurotoxicity has not been fully defined. Here, we investigated CREB2 function in oxidative glutamate toxicity using HT22 hippocampal neurons, primary mouse hippocampal cells, and a kainic acid (KA)-injected rat model. Oxidative stress was induced by glutamate, intracellular ROS levels were quantified with DCFDA, and the antioxidant N-acetylcysteine (NAC) was used to confirm oxidative dependency. Microglia-derived glutamate was assessed by stimulating BV2 cells with lipopolysaccharide (LPS) and applying glutamate-containing conditioned medium (LPS-CM) to HT22 cells. Exogenous glutamate robustly increased CREB2 expression in HT22 and primary neurons, accompanied by ROS accumulation and cell death, whereas NAC suppressed these effects. Inhibition of p53 by siRNA or pifithrin-α (PFT-α) attenuated glutamate-induced CREB2 upregulation, and CREB2 knockdown blocked GADD45α induction and protected neurons. In Vivo, KA injection caused robust CREB2 upregulation in the damaged CA3 region. Importantly, conditioned medium from LPS-activated BV2 microglia increased CREB2 expression and ROS levels in HT22 cells in an NAC-sensitive manner, supporting a glutamate-associated oxidative mechanism rather than receptor-mediated excitotoxicity. Collectively, these results suggest that CREB2 functions between upstream p53 signaling and downstream GADD45α activation as a redox-sensitive mediator of oxidative neuronal death, and may represent a potential therapeutic target in neurodegenerative diseases associated with oxidative stress and neuroinflammation.Keywords
Funding Information
- Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare (2710086662/RS-2025-02213662)
- National Research Foundation of Korea (RS-2023-00246655 and RS-2024-00356135)
This publication has 49 references indexed in Scilit:
- AMPA Receptors in Synaptic Plasticity, Memory Function, and Brain DiseasesCellular and Molecular Neurobiology, 2025
- The role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosisCell Calcium, 2018
- NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administrationGlia, 2013
- Glutamate receptors, neurotoxicity and neurodegenerationPflügers Archiv - European Journal of Physiology, 2010
- Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cellsEuropean Journal of Pharmacology, 2009
- Activating transcription factor 4The International Journal of Biochemistry & Cell Biology, 2008
- CREB and NF-κB Transcription Factors Regulate Sensitivity to Excitotoxic and Oxidative Stress Induced Neuronal Cell DeathCellular and Molecular Neurobiology, 2006
- Kainic acid seizures in the ratProgress in Neurobiology, 1994
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Displacement of synaptic terminals from regenerating motoneurons by microglial cellsCell and tissue research, 1968